Alvin Hernandez Rivera, MD
Internal Medicine · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rivera’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A124000 · Current
Licensed to practise in California · since 2012 · expires 2028-07-31 · Michigan State University College of Human Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$113,310
Medicare paid this office $113,310 for 339 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 243 | $78,059 | $104 |
| Hospital discharge day management, more than 30 minutes | 182 | $19,342 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $8,564 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $4,412 | $69 |
Who their Medicare patients are
339 Original Medicare patients in 2024. Average age 77 · Under 65 11% · 85 and older 27% · Women 52% · Also on Medicaid 61% · Health risk score 3.17. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 60% · Heart failure 55% · Diabetes 53% · Coronary heart disease 45% · Atrial fibrillation 41% · Depression 36% · COPD 33% · Dementia 29% · Stroke 26% · Cancer 22%.
The office billed $416,720, Medicare allowed $144,377 and paid $113,310; for 1,099 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 339 | 1,099 | 77 | 3.17 | $416,720 | $113,310 |
| 2023 | 296 | 960 | 76 | 2.94 | $363,041 | $101,494 |
| 2022 | 300 | 967 | 77 | 2.86 | $336,704 | $85,532 |
| 2021 | 344 | 987 | 76 | 3.31 | $345,478 | $92,275 |
| 2020 | 285 | 916 | 75 | 3.26 | $323,204 | $85,053 |
| 2019 | 374 | 1,099 | 73 | 3.21 | $402,428 | $102,524 |
| 2018 | 350 | 1,089 | 74 | 3.20 | $387,910 | $100,187 |
| 2017 | 346 | 1,241 | 73 | 3.19 | $429,976 | $112,505 |
| 2016 | 344 | 1,097 | 76 | 2.55 | $374,299 | $95,157 |
| 2015 | 416 | 1,015 | 75 | 3.00 | $354,402 | $90,622 |
| 2014 | 59 | 78 | 74 | 3.15 | $40,788 | $10,531 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 204 | $67,154 | $107 |
| Hospital discharge day management, more than 30 minutes | 148 | $15,804 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $9,888 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $6,777 | $72 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 202 | $52,001 | $91 |
| Hospital discharge day management, more than 30 minutes | 168 | $16,491 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $9,649 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,698 | $174 |
| Hospital observation care on day of discharge | 17 | $1,078 | $63 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 206 | $53,472 | $94 |
| Hospital discharge day management, more than 30 minutes | 181 | $17,740 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $8,770 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,795 | $177 |
| Advance care planning, first 30 minutes | 12 | $873 | $73 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 176 | $48,752 | $96 |
| Hospital discharge day management, more than 30 minutes | 150 | $15,226 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $12,126 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $6,814 | $170 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 226 | $55,176 | $91 |
| Hospital discharge day management, more than 30 minutes | 181 | $18,038 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $15,175 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $9,669 | $64 |
2018: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 229 | $59,378 | $91 |
| Hospital discharge day management, more than 30 minutes | 191 | $18,951 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,240 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $7,438 | $64 |
| Hospital observation care on day of discharge | 11 | $704 | $64 |
2017: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 248 | $77,472 | $90 |
| Hospital discharge day management, more than 30 minutes | 187 | $19,101 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,737 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $6,576 | $62 |
2016: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 207 | $55,027 | $86 |
| Hospital discharge day management, more than 30 minutes | 176 | $16,319 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $10,782 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $10,478 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $673 | $34 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 190 | $39,196 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $22,153 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $12,548 | $61 |
| Hospital discharge day management, more than 30 minutes | 85 | $7,942 | $90 |
| Hospital discharge day management, 30 minutes or less | 71 | $4,526 | $63 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,126 | $87 |
| Ultrasound follow-up study | 32 | $550 | $17 |
2014: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,706 | $171 |
Medicaid work
$7,308 in 2024
Medicaid paid $7,308 for 265 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 251 | $6,986 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 14 | $322 |
| 2024 | 265 | 2 | 19 | $7,308 |
| 2023 | 321 | 2 | 20 | $11,659 |
| 2022 | 403 | 2 | 18 | $14,514 |
| 2021 | 233 | 2 | 18 | $7,843 |
| 2020 | 17 | 1 | 16 | $310 |
| 2019 | 187 | 2 | 20 | $5,894 |
| 2018 | 178 | 2 | 17 | $3,352 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 294 | $10,941 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 27 | $718 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 325 | $11,977 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 78 | $2,537 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 193 | $6,199 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 40 | $1,644 |
2020
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 17 | $310 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 175 | $5,685 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $208 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 144 | $2,751 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 34 | $601 |
Drugs they prescribed that Part D paid
$35,918
Pharmacies billed $35,918 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (30 of 359) in 2024. A higher opioid share than 9 in 10 peers; the typical internal medicine clinician is at 1%.
303 generic and fewer than 11 brand-name prescriptions · $35,918 in drug cost · 55 antibiotic prescriptions to 42 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 16 | $164 | $10 |
| Amoxicillin-Clavulanate Potass | 15 | $84 | $6 |
| Atorvastatin | 12 | $47 | $3 |
| Prednisone | 13 | $44 | $3 |
| Pantoprazole | 12 | $38 | $3 |
See all 7 drugs
| Hydrocodone-Acetaminophen | 16 | $164 | $10 |
| Amoxicillin-Clavulanate Potass | 15 | $84 | $6 |
| Atorvastatin | 12 | $47 | $3 |
| Prednisone | 13 | $44 | $3 |
| Pantoprazole | 12 | $38 | $3 |
| Doxycycline Hyclate | 11 | $31 | $3 |
| Carvedilol | 11 | $25 | $2 |
Year by year
| 2024 | 359 | 130 | 8% (30) | None | $35,918 |
| 2023 | 381 | 134 | 7% (27) | None | $49,066 |
| 2022 | 355 | 133 | 7% (26) | 13% | $27,467 |
| 2021 | 253 | 111 | 10% (24) | None | $15,461 |
| 2020 | 259 | 91 | 5% (14) | None | $17,953 |
| 2019 | 320 | 123 | 7% (21) | None | $23,943 |
| 2018 | 492 | 131 | 5% (25) | None | $34,258 |
| 2017 | 353 | 123 | 10% (34) | None | $27,097 |
| 2016 | 300 | 112 | 10% (30) | None | $18,656 |
| 2015 | 319 | 109 | 9% (28) | None | $18,002 |
| 2014 | 119 | 39 | None | 24% | $4,435 |
| 2013 | 113 | 41 | 0% (0) | None | $6,955 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Eliquis | 16 | $10,518 | $657 |
| Metoprolol | 16 | $320 | $20 |
| Amoxicillin-Clavulanate Potass | 25 | $309 | $12 |
| Atorvastatin | 21 | $262 | $12 |
| Pantoprazole | 16 | $243 | $15 |
| Clopidogrel | 12 | $212 | $18 |
| Hydrocodone-Acetaminophen | 24 | $157 | $7 |
| Metoprolol | 11 | $139 | $13 |
| Prednisone | 15 | $139 | $9 |
| Amlodipine Besylate | 17 | $135 | $8 |
2022: 8 drugs
| Pantoprazole | 23 | $277 | $12 |
| Amoxicillin-Clavulanate Potass | 24 | $261 | $11 |
| Ondansetron Odt | 11 | $193 | $18 |
| Doxycycline Hyclate | 12 | $116 | $10 |
| Hydrocodone-Acetaminophen | 16 | $115 | $7 |
| Amlodipine Besylate | 11 | $99 | $9 |
| Atorvastatin | 14 | $90 | $6 |
| Metoprolol | 11 | $34 | $3 |
2021: 3 drugs
| Hydrocodone-Acetaminophen | 19 | $139 | $7 |
| Amoxicillin-Clavulanate Potass | 18 | $128 | $7 |
| Carvedilol | 12 | $70 | $6 |
2020: 5 drugs
| Pantoprazole | 11 | $139 | $13 |
| Amoxicillin-Clavulanate Potass | 15 | $127 | $8 |
| Atorvastatin | 11 | $113 | $10 |
| Furosemide | 16 | $56 | $3 |
| Carvedilol | 12 | $52 | $4 |
2019: 6 drugs
| Clopidogrel | 14 | $356 | $25 |
| Atorvastatin | 21 | $324 | $15 |
| Pantoprazole | 15 | $169 | $11 |
| Carvedilol | 15 | $143 | $10 |
| Hydrocodone-Acetaminophen | 11 | $97 | $9 |
| Amoxicillin-Clavulanate Potass | 13 | $96 | $7 |
2018: 10 drugs
| Xarelto | 12 | $6,793 | $566 |
| Clopidogrel | 29 | $551 | $19 |
| Atorvastatin | 34 | $548 | $16 |
| Carvedilol | 32 | $200 | $6 |
| Hydrocodone-Acetaminophen | 18 | $178 | $10 |
| Levofloxacin | 16 | $156 | $10 |
| Pantoprazole | 15 | $140 | $9 |
| Lisinopril | 16 | $106 | $7 |
| Furosemide | 20 | $95 | $5 |
| Amlodipine Besylate | 19 | $90 | $5 |
2017: 6 drugs
| Levofloxacin | 27 | $426 | $16 |
| Hydrocodone-Acetaminophen | 19 | $119 | $6 |
| Prednisone | 16 | $77 | $5 |
| Carvedilol | 13 | $58 | $4 |
| Lisinopril | 13 | $44 | $3 |
| Furosemide | 14 | $38 | $3 |
2016: 6 drugs
| Hydrocodone-Acetaminophen | 21 | $277 | $13 |
| Amoxicillin-Clavulanate Potass | 13 | $259 | $20 |
| Levofloxacin | 21 | $126 | $6 |
| Amlodipine Besylate | 13 | $99 | $8 |
| Prednisone | 16 | $64 | $4 |
| Carvedilol | 12 | $63 | $5 |
2015: 7 drugs
| Tamsulosin | 11 | $494 | $45 |
| Pantoprazole | 18 | $365 | $20 |
| Clopidogrel | 16 | $320 | $20 |
| Hydrocodone-Acetaminophen | 21 | $241 | $11 |
| Metoprolol | 17 | $238 | $14 |
| Lisinopril | 23 | $159 | $7 |
| Levofloxacin | 20 | $157 | $8 |
2014: 1 drug
| Lisinopril | 13 | $162 | $12 |
Money from drug and device companies
$122 in 2025
| 2025 | 1 | 1 | None | $122 |
| 2019 | 2 | 3 | None | $127 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | Tzield | $122 | 1 payment
|
See the published payment
| Sanofi-Aventis U.S. | Meals · 2025-09-18 | Tzield | $122 |
See earlier years (2019)
2019: $127
| Janssen Pharmaceuticals | Xarelto | $95 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $31 | 2 payments
|
Professional record
- NPI
- 1417213422
- Licence
- CA A124000California A124000: Current · expires 2028-07-31
- Trained
- Michigan State University College of Human Medicine, 2011
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Hospitalist (208M00000X); Internal medicine (207R00000X)
- Mailing address
- 3687 Mt Diablo Blvd, Suite 200, Lafayette, CA, 94549
- NPI first listed
- 2012-04-03
- NPI last updated
- 2017-05-18
This is when the NPI record was last certified, not a medical board exam.